Status:
UNKNOWN
Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Institut Català de la Salut
Conditions:
Characteristics Disease
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Objectives: The primary objective is to identify and characterize the relevant subgroups ( clusters ) in type 2 diabetes (T2DM) at the time of diagnosis in our region. This objective will be addressed...
Detailed Description
A multicenter prospective observational study will be conducted. The study design contemplates a single visit that will coincide with the inclusion of the patient in the study. Prior to the inclusion ...
Eligibility Criteria
Inclusion
- Subjects of both sexes, of legal age (≥18 years)
- Newly diagnosed T2DM according to the criteria of the American Diabetes Association
- With a maximum duration of three months of the disease at the time of inclusion.
- Writen informed consent
Exclusion
- Subjects with a new diagnosis of other types of diabetes (type 1, MODY, gestational or other causes) will also be evaluated to ensure that the diagnostic criteria for selection are correctly implemented in all potential study participants.
- \*For final analysis, subjects with any diagnosis of diabetes other than T2DM will be excluded from the study.
Key Trial Info
Start Date :
March 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05333718
Start Date
March 8 2022
End Date
December 31 2025
Last Update
April 19 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Santa Creu i Sant Pau
Barcelona, Catalonia, Spain, 08025
2
Institut Català de la Salut
Barcelona, Catalonia, Spain, 08025